Leccurate COVID-19 antibody test

Lepu Medical Leccurate
Leccurate COVID-19 antibody test that provides rapid results to determine the Coronavirus. It is based on the presence of IgG and/or IgM from a blood sample. The rapid test is produced by Chinese company Beijing Lepu Medical Technology.

 

Description

Leccurate COVID-19 antibody test that provides rapid results to determine the Coronavirus. It is based on the presence of IgG and/or IgM from a blood sample. The rapid test is produced by Chinese company Beijing Lepu Medical Technology.

The Leccurate SARS-CoV-2 clarifies within 15 minutes if antibodies have been produced against the Coronavirus (SARS-CoV-2 infection). The rapid test detects the presence of SARS-CoV-2 antibodies, however, should not be used as the sole criterion of a COVID-19 diagnosis. More information about this rapid antibody test, read Leccurate, everything you need to know

The test is widely used in China, Europe, USA and Russia. For instance the Novosibirsk hospital “Medsanchast-168” uses the test.

The rapid test for COVID-19 will be applied to Grupo Kattan collaborators in Honduras. With the help of experts in microbiology, the Kattan Group decided that the rapid test with 98% reliability that existed in the market was Leccurate, so, with the support of certified laboratories, it decided to import it to start applying the test. “For the reliability of the results, the application of the rapid test must be carried out by health specialists, doctors in Microbiology accompanied by technicians in a clinical laboratory,” said Dr. Ramos.

The rapid test is sold online in kits containing 20 tests and costs about € 250,-.

Studies on the accuracy of the leccurate covid-19 antibody test are available on request over at Leccurate’s official website.

Reviews

There are no reviews yet.

Be the first to review “Leccurate COVID-19 antibody test”

Your email address will not be published. Required fields are marked *

Go to Top